U.S. Markets open in 60 hrs, 24 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 17.01 12:09 PM EDT | |
|---|---|---|
| Day High | 17.8268 09:32 AM EDT |
|
| Range | 0.82 |
| Volume | 744,222 | |
|---|---|---|
| 30-Day Avg Vol | 634,000 |
|
| Difference | 17.39% |
| Market Cap | 988.91 M | |
|---|---|---|
| Mkt Cap Chg | -34.57 M |
| Shares Out | 57.62 M | |
|---|---|---|
| % Shrs Traded | 1.29% | |
| 1yr EPS Est | 1.444 |
| 52-Wk Low | 13.81 3/5/09 | |
|---|---|---|
| 52-Wk High | 28.74 12/4/08 |
|
| Range | 14.93 |
| Prev Close | 17.76 7/1/09 | |
|---|---|---|
| Today's Open | 17.76 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.94 M |
| Revenue (LFY) | 433.64 M | |
|---|---|---|
| Earnings (LFY) | 169.82 M | |
| Earnings (MRQ) | 7.78 M | |
| Next Earn Est | 0.276 | |
| Next Earnings | 07/16/2009 |
|
| EPS (TTM) | 2.42 | |
| 1yr EPS Growth | -40.33% |
| P/E Ratio (TTM) | 6.81 | |
|---|---|---|
| P/E Ratio (Fwd) | 11.00 | |
| PEG Ratio | 0.48 | |
| Return on Equity | 73.19 | |
| Beta | 0.70 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
CNBC Video
Fighting infection is a modern art form at Cubist Pharmaceuticals. The company is developing antimicrobial agents that aim to treat drug-resistant infections typically found in hospitals and other health ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.276 7/16/09 | — — |
—
—
|
| Last Quarter | 0.104 3/31/09 | 0.13 3/31/09 |
0.026
Beat
|
| 2 Quarters Ago | 0.52 12/31/08 | 1.82 12/31/08 |
1.30
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 121.11 M | 433.64 M |
| Gross Profit | 96.74 M | 343.26 M |
| Operating Income | 15.79 M | 93.19 M |
| Net Income | 7.78 M | 169.82 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts